Opportunities and challenges for transcriptome-wide association studies. Wainberg Michael et al. Nature genetics 2019 51(4) 592-599

Main|Search|PHGKB




Last Posted: May 07, 2019

---

• Opportunities and challenges for transcriptome-wide association studies.
  Wainberg Michael et al. Nature genetics 2019 51(4) 592-599
• The role of the NOD2/CARD15 gene in surgical treatment prediction in patients with Crohn's disease.
  Kunovsky L et al. International journal of colorectal disease 2019 Feb 34(2) 347-351
• A blood-based prognostic biomarker in IBD.
  Biasci Daniele et al. Gut 2019 Apr
• Personalised medicine in inflammatory bowel diseases: a patient survey.
  Choukour Myriam et al. Scandinavian journal of gastroenterology 2019 54(1) 135
• Biomedical risk assessment as an aid for smoking cessation.
  Clair Carole et al. The Cochrane database of systematic reviews 2019 Mar 3CD004705
• Personalising medicine in inflammatory bowel disease-current and future perspectives.
  Ashton James J et al. Translational pediatrics 2019 Jan 8(1) 56-69
• SLC39A8 missense variant is associated with Crohn's disease but does not have a major impact on gut microbiome composition in healthy subjects.
  Collij Valerie et al. PloS one 2019 (1) e0211328
• Microbial network disturbances in relapsing refractory Crohn's disease.
  Yilmaz Bahtiyar et al. Nature medicine 2019 Jan
• Clinical and Genetic Aspects of Behçet's Disease in Japan.
  Kirino Yohei et al. Internal medicine (Tokyo, Japan) 2019 Jan
• PRedicting Outcomes For Crohn's dIsease using a moLecular biomarkEr (PROFILE): protocol for a multicentre, randomised, biomarker-stratified trial.
  Parkes Miles et al. BMJ open 2018 Dec 8(12) e026767

more